Efficacy and safety of imatinib mesylate (Gleevec®) and immunohistochemical expression of c-Kit and PDGFR-β in a Gynecologic Oncology Group Phase Il Trial in women with recurrent or persistent carcinosarcomas of the uterus

✍ Scribed by Warner K. Huh; Michael W. Sill; Kathleen M. Darcy; Kevin M. Elias; James S. Hoffman; John F. Boggess; Ronald D. Alvarez; Harry J. Long; David M. O'Malley; Michael J. Birrer

• Book ID: 113962377
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 264 KB
• Volume: 117
• Category: Article
• ISSN: 0090-8258
• DOI: 10.1016/j.ygyno.2010.01.002